Global Perspectives in Gynecologic Malignancies 2022
Expert perspectives and strategic insights on the latest therapeutic developments in gynecologic malignancies.
March 26, 2022
Faculty Chair
Robert Coleman, MD
University of Texas, MD Anderson Cancer Center, Houston, TX, USA
FACULTY MEMBERS
Bradley Monk, MD
Biltmore Cancer Center, AZ, USA
Jalid Sehouli, MD
Charité University Hospital, Berlin, Germany
Thomas Herzog, MD
University of Cincinnati Cancer Institute, OH, USA
Brian Slomovitz, MD
Mount Sinai Medical Center, FL, USA
Ana Oaknin, MD, PhD
Vall d’Hebron Institute of Oncology, Barcelona, Spain
Matthew Powell, MD
Washington University, MO, USA
David O’Malley, MD
Ohio State University College of Medicine, OH, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Early Stage Ovarian Cancer
- Advanced Ovarian Cancer: First-Line and Maintenance Therapy
- Advanced Ovarian Cancer: Treatment Strategies in the Relapsed Setting
- Advanced Endometrial Cancer: Current Treatment and Future Directions
- Advanced Cervical Cancer: Current Treatment and Future Directions
